| |
| Issue |
Title |
| |
| Vol 21, No 3 (2025) |
Rivaroxaban in stroke prevention in patients with non-valvular atrial fibrillation: what facts are important for the clinician? |
Abstract
PDF (Rus)
|
|
I. S. Yavelov |
| |
| Vol 21, No 3 (2025) |
Direct methods for assessing adherence to antihypertensive therapy: witnessed intake and therapeutic drug monitoring |
Abstract
PDF (Rus)
|
|
M. V. Ionov, I. V. Emelyanov, A. O. Konradi |
| |
| Vol 21, No 3 (2025) |
Effectiveness of fixed-dose combination of rosuvastatin and ezetimibe in heterozygous familial hypercholesterolemia from the RENAISSANCE registry |
Abstract
PDF (Rus)
|
|
I. A. Alekseeva, U. V. Chubykina, M. V. Ezhov, A. V. Tyurina, T. E. Kolmakova, N. A. Tmoyan, A. A. Sokolov, T. A. Rozhkova, N. S. Kurochkina, I. V. Sergienko, I. V. Avdeeva, V. E. Oleynikov, A. S. Alieva, N. G. Androsyuk, M. A. Kiselevа, Yu. G. Grigorieva, A. S. Asekritova, E. S. Kylbanova, A. V. Pavlova, A. I. Ershova, A. N. Meshkov, V. I. Mikhailina, A. V. Blokhina, A. S. Limonova, O. V. Kopylova, A. S. Vorobyev, I. D. Astrakhantseva, Yu. A. Vorobyeva, Yu. A. Ermakova, D. I. Sadykova, E. S. Slastnikova, L. F. Galimovа, I. I. Shaposhnik, V. V. Genkel, A. V. Egorova, N. V. Mukha, P. V. Vasilenko, D. N. Zaitsev, Z. F. Kim, V. K. Zafiraki, M. V. Zykov, V. A. Korneva, T. Yu. Kuznetsova, Yu. A. Malyshenko, T. I. Petelina, E. V. Mikova, A. M. Namitokov, E. D. Kosmacheva, I. I. Pshenichnikova, V. O. Konstantinov, S. E. Bednova, M. I. Voevoda, O. V. Timoshenko, Yu. I. Ragino, A. E. Filippov, A. M. Tuktarov, V. S. Gurevich, M. V. Muzalevskaya, S. A. Urazgildeevа, R. A. Khokhlov, S. V. Yarkovaya, E. A. Shutemova, E. V. Kudelkina, N. N. Bizyaeva |
| |
| Vol 21, No 2 (2025) |
Replenishment of intracellular magnesium deficiency in cardiac arrhythmias: focus on the physicochemical properties of complex compounds |
Abstract
PDF (Rus)
|
|
Ya. G. Bozhko, N. A. Belokonova, O. M. Medvedeva, K. A. Butova, M. V. Arkhipov |
| |
| Vol 21, No 2 (2025) |
Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation |
Abstract
PDF (Rus)
|
|
E. A. Naryshkina, M. I. Chashkina, E. S. Zadykyan, N. K. Kurbanalieva, E. M. Zakaryan, M. V. Serova, D. A. Andreev, A. G. Komarova, K. E. Eroshkin, A. A. Kulesh, D. A. Sychev |
| |
| Vol 21, No 1 (2025) |
The no-reflow phenomenon: current treatment and prevention strategies |
Abstract
PDF (Rus)
|
|
S. V. Dil, E. V. Vyshlov, M. A. Kercheva, L. N. Maslov, V. V. Ryabov |
| |
| Vol 21, No 1 (2025) |
Practical aspects of perioperative management in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants |
Abstract
PDF (Rus)
|
|
E. N. Markova, T. Yu. Vedenikin, A. A. Kuzub, N. V. Kuchieva, A. R. Navasardyan, O. N. Dzhioeva |
| |
| Vol 20, No 5 (2024) |
Lipoprotein(a), atherosclerosis and cardiovascular risk |
Abstract
PDF (Rus)
|
|
E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher |
| |
| Vol 20, No 5 (2024) |
Russian extreme hypertriglyceridemia registy (REGGI): a call to action |
Abstract
PDF (Rus)
|
|
U. V. Chubykina, M. V. Ezhov, A. A. Sokolov, P. A. Vasiluev, O. N. Ivanova, E. Y. Zakharova |
| |
| Vol 20, No 5 (2024) |
Prospects for the use of anti-inflammatory therapy in patients with coronary artery disease |
Abstract
PDF (Rus)
|
|
N. M. Abduzhamalova, M. N. Mamedov |
| |
| Vol 20, No 4 (2024) |
Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension |
Abstract
PDF (Rus)
|
|
O. B. Kuzmin, N. V. Buchneva, V. V. Belyanin, V. V. Zhezha, M. V. Stolbova |
| |
| Vol 20, No 3 (2024) |
NLRP3 Inflammasome — a new universal target of asymptomatic hyperuricemia and gout management |
Abstract
PDF (Rus)
|
|
P. A. Lebedev, L. T. Volova, N. K. Osina, E. V. Paranina |
| |
| Vol 20, No 3 (2024) |
Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM |
Abstract
PDF (Rus)
|
|
N. S. Kostritca, R. M. Rabinovich, R. M. Shakhnovich, I. S. Yavelov, R. G. Gulyan, Yu. K. Rytova, S. N. Tereschenko, A. D. Erlikh, D. V. Pevzner |
| |
| Vol 20, No 2 (2024) |
Cardiotoxicity mechanisms of antitumor therapy with immune checkpoint inhibitors: new achievements |
Abstract
PDF (Rus)
|
|
L. D. Khidirova, A. E. Latsvieva, A. V. Vederin |
| |
| Vol 20, No 1 (2024) |
Prevention of complications during implantation of devices in arrhythmology, past, present and future |
Abstract
PDF (Rus)
|
|
O. R. Eshmatov, R. E. Batalov, S. N. Krivolapov, M. S. Khynin, E. S. Sitkova, L. A. Pokrovskaya, E. M. Berezina, V. V. Botvin |
| |
| Vol 20, No 1 (2024) |
Practical approaches to antimicrobial therapy for infective endocarditis in the context of national and European clinical guidelines |
Abstract
PDF (Rus)
|
|
E. O. Kotova, Zh. D. Kobalava |
| |
| Vol 19, No 6 (2023) |
Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible? |
Abstract
PDF (Rus)
|
|
V. D. Zakiev, N. M. Vorobyeva, I. P. Malaya, A. D. Gvozdeva, O. N. Tkacheva |
| |
| Vol 19, No 5 (2023) |
Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes |
Abstract
PDF (Rus)
|
|
A. M. Kochergina, O. L. Barbarash |
| |
| Vol 19, No 3 (2023) |
Nutraceutical support in the prevention and treatment of cardiovascular diseases |
Abstract
PDF (Rus)
|
|
E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka |
| |
| Vol 19, No 3 (2023) |
Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevsky, N. K. Vereina, M. V. Golshmid |
| |
| Vol 19, No 4 (2023) |
Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevsky, D. O. Ladygina |
| |
| Vol 19, No 2 (2023) |
Vasotoxic Effects of Anticancer Therapy: a Review of Current Data |
Abstract
PDF (Rus)
|
|
Yu. A. Vasyuk, E. Y. Shupenina, A. G. Nosova, E. O. Novosel, D. A. Vyzhigin |
| |
| Vol 19, No 2 (2023) |
Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity? |
Abstract
PDF (Rus)
|
|
A. M. Chaulin, D. V. Duplyakov |
| |
| Vol 19, No 1 (2023) |
Value of Safety of Anticoagulant Therapy in Elderly Patient with Atrial Fibrillation and High Risk of Bleeding |
Abstract
PDF (Rus)
|
|
N. M. Vorobyeva, O. N. Tkacheva |
| |
| Vol 19, No 1 (2023) |
A Case of Successful Medical Treatment of Ventricular Tachycardia in a Patient With Ischemic Heart Disease and Heart Failure |
Abstract
PDF (Rus)
|
|
E. A. Ryngach, A. A. Tatarinova, E. S. Zhabina, O. N. Zhdanova, T. V. Treshkur |
| |
| Vol 19, No 1 (2023) |
Relief of persistent atypical atrial flutter: experience with the use of niferidil |
Abstract
PDF (Rus)
|
|
E. A. Zakharyan, D. V. Shatov, A. O. Povoroznyj, T. B. Bujar |
| |
| Vol 18, No 6 (2022) |
Perioperative Management of Patients Receiving Antithrombotic Therapy in Schemes and Algorithms |
Abstract
PDF (Rus)
|
|
O. N. Dzhioeva, E. A. Rogozhkina, O. M. Drapkina |
| |
| Vol 18, No 6 (2022) |
Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants |
Abstract
PDF (Rus)
|
|
A. D. Aga, A. A. Sokolova, D. A. Napalkov |
| |
| Vol 18, No 6 (2022) |
The Pathogenetic Basis of the Action of Bempedoic Acid |
Abstract
PDF (Rus)
|
|
A. S. Petrosyan, R. S. Rud', P. P. Polyakov, A. Kh. Kade, S. A. Zanin |
| |
| Vol 18, No 5 (2022) |
Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review |
Abstract
PDF (Rus)
|
|
B. A. Tatarsky, N. V. Kazennova |
| |
| Vol 18, No 5 (2022) |
A New Chapter in the Treatment of Patients with Heart Failure. The Role of Sodium-Glucose Co-transporter Type 2 Inhibitors |
Abstract
PDF (Rus)
|
|
D. P. Golubovskaya, V. N. Karetnikova, I. R. Oleinik, O. L. Barbarash |
| |
| Vol 18, No 4 (2022) |
Therapeutic Options for the Single Pill Combination of Lisinopril, Amlodipine and Rosuvastatin: a Systematic Review |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevsky, M. V. Golshmid, N. G. Bendeliani |
| |
| Vol 18, No 3 (2022) |
Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevsky |
| |
| Vol 18, No 3 (2022) |
Dynamics of 6-Minute Walk Distance as a Predictor of Efficiency Specific Pulmonary Vasodilators |
Abstract
PDF (Rus)
|
|
A. A. Shmalts |
| |
| Vol 18, No 3 (2022) |
Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice |
Abstract
PDF (Rus)
|
|
V. L. Doshchitsin, A. I. Tarzimanova |
| |
| Vol 18, No 2 (2022) |
The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects |
Abstract
PDF (Rus)
|
|
N. B. Lebedeva, L. Yu. Chesnokova |
| |
| Vol 18, No 2 (2022) |
The problem of choice: original drug or generic? Emphasis on rosuvastatin |
Abstract
PDF (Rus)
|
|
O. A. Polyakova, O. D. Ostroumova |
| |
| Vol 18, No 2 (2022) |
Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases |
Abstract
PDF (Rus)
|
|
A. N. Zakirova, N. E. Zakirova |
| |
| Vol 18, No 1 (2022) |
Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future |
Abstract
PDF (Rus)
|
|
A. M. Chaulin, D. V. Duplyakov |
| |
| Vol 18, No 1 (2022) |
Cardiovascular Effects of Metformin |
Abstract
PDF (Rus)
|
|
B. T. Kurmanbekova, A. M. Noruizbaeva |
| |
| Vol 17, No 6 (2021) |
Atrial Fibrillation in Cancer Patients: Who is at Risk? |
Abstract
PDF (Rus)
|
|
Yu. A. Vasyuk, E. Yu. Shupenina, D. A. Vyzhigin, E. O. Novosel, K. V. Gallinger |
| |
| Vol 17, No 6 (2021) |
Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 |
Abstract
PDF (Rus)
|
|
I. S. Yavelov |
| |
| Vol 17, No 6 (2021) |
Renal Function Protection as an Important Component of a Comprehensive Approach to the Management of Patients with Atrial Fibrillation |
Abstract
PDF (Rus)
|
|
T. V. Pavlova |
| |
| Vol 17, No 5 (2021) |
Gastrointestinal Bleeding: a Cardiologist's Point of View |
Abstract
PDF (Rus)
|
|
O. V. Averkov, L. N. Mishchenko |
| |
| Vol 17, No 5 (2021) |
Peculiarities of Adverse Events Manifested by Injury of Skin and Skin Derivatives and Associated with Beta-blockers Use |
Abstract
PDF (Rus)
|
|
A. V. Matveev, E. A. Egorova, E. I. Konyaeva, A. G. Dormidor, E. Yu. Bekirova |
| |
| Vol 17, No 5 (2021) |
Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case |
Abstract
PDF (Rus)
|
|
A. A. Avagimyan, L. H. Mkrtchyan, A. A. Gevorkyan, N. B. Kononchuk, L. V. Kakturskiy, Z. T. Djndoyan |
| |
| Vol 17, No 4 (2021) |
Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention |
Abstract
PDF (Rus)
|
|
A. V. Panov |
| |
| Vol 17, No 3 (2021) |
Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome |
Abstract
PDF (Rus)
|
|
A. Yu. Proshlyakov, P. Sh. Chomakhidze, N. A. Novikova |
| |
| Vol 17, No 3 (2021) |
Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects |
Abstract
PDF (Rus)
|
|
P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina |
| |
| Vol 17, No 3 (2021) |
An Integrated Approach to the Management of a Multimorbid Patient with Atrial Fibrillation from the Standpoint of Modern Guidelines: Rivaroxaban is in Focus |
Abstract
PDF (Rus)
|
|
V. N. Larina, O. Sh. Oynotkinova, A. P. Majorova, G. A. Egiazarian, T. Yu. Demidova |
| |
| Vol 17, No 2 (2021) |
Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease |
Abstract
PDF (Rus)
|
|
T. Yu. Demidova, O. A. Kislyak |
| |
| Vol 17, No 2 (2021) |
Laboratory predictors of clinical outcomes in patients with atrial fibrillation |
Abstract
PDF (Rus)
|
|
A. A. Sokolova, I. V. Goncharova, A. A. Vedernikov, N. S. Morozova, D. A. Napalkov |
| |
| Vol 17, No 2 (2021) |
Management of Patients with Chronic Heart Failure and Diabetes Mellitus |
Abstract
PDF (Rus)
|
|
E. V. Reznik, T. L. Nguyen, G. N. Golukhov |
| |
| Vol 17, No 2 (2021) |
The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 |
Abstract
PDF (Rus)
|
|
V. I. Podzolkov, A. I. Tarzimanova |
| |
| Vol 17, No 2 (2021) |
Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage |
Abstract
PDF (Rus)
|
|
A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov |
| |
| Vol 17, No 2 (2021) |
Treatment of Vasovagal Syncope Associated with Asystole: Literature Review and Case Report of Long-term Follow-up |
Abstract
PDF (Rus)
|
|
A. V. Pevzner, E. A. Kuchinskaya, V. G. Kiktev, G. I. Kheimets |
| |
| Vol 17, No 1 (2021) |
A Clinical Case: the Risk Factors of Acute Kidney Injury in a Cardiological Patient |
Abstract
PDF (Rus)
|
|
E. A. Son, M. R. Kondratyuk, E. V. Fominykh, V. V. Fomin |
| |
| Vol 17, No 1 (2021) |
Pharmacokinetics and Pharmacogenetics of Dabigatran |
Abstract
PDF (Rus)
|
|
A. V. Savinova, V. S. Dobrodeeva, M. M. Petrova, R. F. Nasyrova, N. A. Shnayder |
| |
| Vol 17, No 1 (2021) |
Modern trends in identification of causative agents in infective endocarditis |
Abstract
PDF (Rus)
|
|
E. O. Kotova, E. A. Domonova, Zh. D. Kobalava, J. L. Karaulova, A. S. Pisaryuk, A. V. Balatskiy, V. G. Akimkin |
| |
| Vol 17, No 1 (2021) |
Additional Features in the Treatment of Patients with Chronic Heart Failure. From EMPA-REG OUTCOME Study to EMPEROR-REDUCED Study. Resolution of the On-line Scientific Meeting of Moscow Experts |
Abstract
PDF (Rus)
|
|
A. Yu. Lebedeva, O. M. Koteshkova, O. N. Dzhioeva, S. R. Gilyarevsky, T. M. Uskach, M. S. Novikova, Ya. A. Orlova, V. Yu. Kalashnikov, D. V. Privalov, N. A. Ananicheva, M. Yu. Gilyarov, A. D. Erlikh |
| |
| Vol 17, No 1 (2021) |
Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council |
Abstract
PDF (Rus)
|
|
M. V. Ezhov, V. V. Kukharchuk, I. V. Sergienko, N. M. Akhmedzhanov, M. I. Voevoda, V. S. Gurevich, V. V. Kashtalap, V. O. Konstantinov, V. V. Skibitsky, I. I. Shaposhnik |
| |
| Vol 17, No 1 (2021) |
Optimization of Pharmacotherapy Within the Framework of a Patient-oriented Approach in the Treatment of Hypertension in Multimorbidity Patients (Clinical Case and Literature Review) |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, I. A. Alyautdinova, S. N. Litvinova, A. V. Arablinskij, A. A. Kirichenko |
| |
| Vol 17, No 1 (2021) |
Registration of Medicines in the Soviet Control and Licensing System on the Example of the Cardiological Drug Trinitrolong |
Abstract
PDF (Rus)
|
|
A. N. Petrenko, P. A. Vasiliev, S. Yu. Martsevich, N. P. Kutishenko, O. I. Zvonareva |
| |
| Vol 16, No 6 (2020) |
Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice? |
Abstract
PDF (Rus)
|
|
T. M. Uskach, A. S. Tereshchenko |
| |
| Vol 16, No 6 (2020) |
Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome |
Abstract
PDF (Rus)
|
|
R. M. Velieva, T. B. Pecherina, A. S. Vorobiev, V. V. Kashtalap, D. Yu. Sedykh |
| |
| Vol 16, No 6 (2020) |
An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? |
Abstract
PDF (Rus)
|
|
T. V. Pavlova |
| |
| Vol 16, No 6 (2020) |
Switching Strategy in the Management of Patients with Pulmonary Arterial Hypertension. The REPLACE Study Results |
Abstract
PDF (Rus)
|
|
E. V. Filippov |
| |
| Vol 16, No 5 (2020) |
Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy? |
Abstract
PDF (Rus)
|
|
Z. D. Kobalava, E. V. Kokhan |
| |
| Vol 16, No 5 (2020) |
Pharmacokinetics and Pharmacogenetics of Apixaban |
Abstract
PDF (Rus)
|
|
A. V. Savinova, M. M. Petrova, N. A. Shnayder, E. N. Bochanova, R. F. Nasyrova |
| |
| Vol 16, No 4 (2020) |
Felodipine in Treatment of Arterial Hypertension and Ischemic Heart Disease |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, I. A. Alautdinova, A. I. Kochetkov, S. N. Litvinova |
| |
| Vol 16, No 4 (2020) |
From Low-Dose Fixed Combinations for Arterial Hypertension Treatment to Multi-Target Therapy of Cardiovascular Diseases |
Abstract
PDF (Rus)
|
|
P. A. Lebedev, A. A. Garanin |
| |
| Vol 16, No 4 (2020) |
Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova |
| |
| Vol 16, No 3 (2020) |
The Possibilities of Single-Pill Combinations of Antihypertensive Drugs in Cerebroprotection: Focus on the Combination of Amlodipine with Ramipril |
Abstract
PDF (Rus)
|
|
A. I. Kochetkov, S. V. Batyukina, O. D. Ostroumova, M. Yu. Nazranova, V. N. Butorov |
| |
| Vol 16, No 3 (2020) |
Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs |
Abstract
PDF (Rus)
|
|
O. V. Gaisenok |
| |
| Vol 16, No 3 (2020) |
The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders |
Abstract
PDF (Rus)
|
|
V. I. Podzolkov, A. I. Tarzimanova |
| |
| Vol 16, No 2 (2020) |
Soluble Guanylate Cyclase Stimulators for Chronic Thromboembolic Pulmonary Hypertension Patients Treatment: New Data |
Abstract
PDF (Rus)
|
|
M. A. Simakova, O. M. Moiseeva |
| |
| Vol 16, No 2 (2020) |
Off-Label Medicines Use: Complex Problem of Modern Clinical Practice |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevskiy |
| |
| Vol 16, No 1 (2020) |
Levocarnitine for the Treatment of Polymorbid Patients |
Abstract
PDF (Rus)
|
|
A. P. Pereverzev, D. A. Shevchenko, A. V. Filippova, A. A. Kirichenko, I. F. Krotkova, O. D. Ostroumova |
| |
| Vol 15, No 6 (2019) |
Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Kochetkov |
| |
| Vol 15, No 6 (2019) |
Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention |
Abstract
PDF (Rus)
|
|
A. S. Tereshchenko, Е. V. Merkulov, A. M. Samko |
| |
| Vol 15, No 5 (2019) |
Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them |
Abstract
PDF (Rus)
|
|
N. V. Pyrikova, O. N. Antropova, I. V. Osipova |
| |
| Vol 15, No 4 (2019) |
Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen |
Abstract
PDF (Rus)
|
|
A. I. Kochetkov, O. D. Ostroumova |
| |
| Vol 15, No 2 (2019) |
A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevskiy, M. V. Golshmid, G. Yu. Zaharova, I. M. Kuzmina, I. I. Sinitsina |
| |
| Vol 15, No 2 (2019) |
How to solve the problem of drug choice within the same class from the standpoint of evidence-based medicine? |
Abstract
PDF (Rus)
|
|
S. Yu. Martsevich |
| |
| Vol 15, No 2 (2019) |
The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention |
Abstract
PDF (Rus)
|
|
A. S. Tereshchenko, E. V. Merkulov, A. N. Samko, S. A. Abugov |
| |
| Vol 15, No 1 (2019) |
Legal and Medical Aspects of Off-Label Medication Use. Point of View |
Abstract
PDF (Rus)
|
|
O. V. Tsygankova, T. I. Batluk, L. D. Latyntseva, D. Y. Platonov, N. M. Akhmedzhanov |
| |
| Vol 14, No 6 (2018) |
Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding |
Abstract
PDF (Eng)
|
|
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin |
| |
| Vol 14, No 6 (2018) |
Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment |
Abstract
PDF (Eng)
|
|
G. V. Ramenskaya, I. E. Shokhin, N. I. Gaponova, V. R. Abdrakhmanov |
| |
| Vol 14, No 5 (2018) |
Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable |
Abstract
PDF (Rus)
|
|
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin |
| |
| Vol 14, No 4 (2018) |
New Clinical Aspects of Eplerenone Use in Clinical Practice |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina |
| |
| Vol 14, No 4 (2018) |
Hepatotoxicity of New Oral Anticoagulants |
Abstract
PDF (Rus)
|
|
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin |
| |
| Vol 14, No 3 (2018) |
TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk |
| |
| Vol 14, No 2 (2018) |
NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov |
| |
| Vol 14, No 1 (2018) |
UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME |
Abstract
PDF (Rus)
|
|
O. V. Krikunova, R. I. Stryuk |
| |
| Vol 13, No 6 (2017) |
THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION |
Abstract
PDF (Rus)
|
|
A. N. Zakirova, B. N. Garifullin, N. E. Zakirova |
| |
| Vol 13, No 5 (2017) |
CHRONOTHERAPY OF HYPERTENSION: CURRENT STATE OF THE SCIENTIFIC PROBLEM |
Abstract
PDF (Rus)
|
|
V. M. Gorbunov, E. Y. Fedorova, E. V. Platonova |
| |
| Vol 13, No 5 (2017) |
DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS |
Abstract
PDF (Rus)
|
|
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov |
| |
| Vol 13, No 4 (2017) |
CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva |
| |
| Vol 13, No 4 (2017) |
PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW |
Abstract
PDF (Rus)
|
|
I. S. Yavelov |
| |
| Vol 13, No 3 (2017) |
BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL |
Abstract
PDF (Rus)
|
|
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov |
| |
| 1 - 100 of 233 Items |
1 2 3 > >>
|
